Third Annual Ropes & Gray Rare Disease Forum

Ropes & Gray recently hosted its Third Annual Ropes & Gray Rare Disease Forum on May 1, 2025, in Cambridge, Massachusetts. The event gathered legal, commercial, and patient advocacy experts in the rare disease community to explore ongoing regulatory reforms, policy changes, legal developments, and shifts in compliance and enforcement risks as we passed the first 100 days of the new administration. Panelists provided timely insights into the implications for the development and commercialization of rare disease products and expressed their outlook on what is to come.

Key topics discussed included the evolving policy landscape, with panelists expressing optimism around rare disease policy objectives despite agency leadership turnover and recent reduction-in-force measures at the U.S. Food and Drug Administration. The forum also addressed the impact of tariffs and global trade policies on rare disease drug supply chains and pricing decisions, highlighting the importance of staying informed and advocating for rare disease patients and the advancement of new therapies.

The event featured networking opportunities, allowing attendees to connect with peers and industry leaders. Notable speakers included experts from legal, commercial, and patient advocacy sectors, providing a comprehensive perspective on the challenges and opportunities within the rare disease community.

This forum is particularly beneficial for legal professionals, policymakers, healthcare providers, and patient advocates involved in the rare disease sector. Attendees gain valuable insights into regulatory developments, policy changes, and strategies for advancing rare disease therapies, making it a must-attend event for those committed to improving outcomes for rare disease patients.